Unlock instant, AI-driven research and patent intelligence for your innovation.

Antiviral actions, implementation method and use of novel antiviral molecule DRP

A kind of use, virus technology, applied in the fields of biotechnology and medicine, can solve the problems that the research of immune function has not yet waited for

Inactive Publication Date: 2010-12-01
SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] Although existing studies have revealed the role of DRP / Nrdp1 in regulating cell growth and apoptosis, there is no research on its immune function.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antiviral actions, implementation method and use of novel antiviral molecule DRP
  • Antiviral actions, implementation method and use of novel antiviral molecule DRP
  • Antiviral actions, implementation method and use of novel antiviral molecule DRP

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0118] Example 1: Stimulation of DRP on the production of IFN-β and interferon-inducible genes in the macrophage cell line RAW264.7 into effect

[0119] First, pcDNA3.1 (purchased from Invitrogen) was used as a eukaryotic expression vector, and the cDNA product of DRP with BamHI / KpnI restriction sites was inserted into the corresponding position of the vector, and amplified in E. Coli strain DH-5α The vector is purified to obtain the eukaryotic expression vector of DRP after sequencing identification. Stable transfection (transfection reagent JetPei was purchased from Polyplus company) mouse RAW264.7 cells (purchased from ATCC), and then the resulting stable transfected cell line (1 × 10 5 cells / ml RPMI 1640 medium), treated with 100ng / ml LPS (also known as lipopolysaccharide, which is the ligand of TLR4, purchased from Sigma Company) for different time, collected cells and culture supernatant, prepared cDNA for quantitative RT -PCR (94°C, 30Sec; 58°C, 30Sec; 72°C, 30Sec;...

Embodiment 2

[0123] Example 2: Overexpression of DRP inhibits the replication and amplification of VSV virus in RAW264.7 cells

[0124] Live VSV (gifted by Professor Shu Hongbing, School of Life Sciences, Wuhan University) and UV-inactivated VSV (VSV-UV) at 0.1 MOI were added to RAW264.7 cells, cultured for 12 hours, and the cells and culture supernatant were collected. Among them, the cells were used to detect the mRNA level of the VSV L gene, and the supernatant was used for the plaque formation experiment (PFU, refer to the literature Xu, L.G. et al. Mol. Cell. 19:727-740 (2005)).

[0125] Test results such as image 3 shown. The results showed that stable overexpression of DRP could significantly inhibit the replication of VSV virus in RAW264.7 cell line and the release of VSV virus into the supernatant.

[0126]The results indicated that overexpression of DRP could inhibit the replication and amplification of VSV virus in macrophage cell lines.

Embodiment 3

[0127] Example 3: Inhibitory effect of DRP adenovirus intravenous injection on the amplification of VSV virus in the liver

[0128] First, pShuttle2 in the Adeno-X virus vector system (purchased from Clontech Company) was used as the cloning vector, and the cDNA of DRP was inserted between the SalI and XhoI restriction sites, and the shuttle plasmid was recombined with the viral DNA in HEK293 cells, and amplified. After the amplification, the adenovirus purification kit (purchased from Clontech Company) was used. 1×10 7 PFU Ad-DRP was injected into the tail vein of mice (6-week-old male SDF-grade C57BL6 mice, purchased from Sipper BK Company), and 48 hours later, VSV virus (5×10 6 PFU / mouse). After 12 or 24 hours, the mouse liver was collected, and the lysate was applied to the plaque formation experiment (PFU, performed with reference to the literature Ciavarra, R.P. et al. Virology. 342: 177-189 (2005)).

[0129] Test results such as Figure 4 shown. The results showe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to antiviral actions, an implementation method and use of a novel antiviral molecule DRP (Death Resistant Protein). The invention provides a using method of the molecule in the process of resisting virus infection and a corresponding immunological principle. The invention discloses the use and strategy of the molecule in resisting virus infection, particularly the use for preventing and curing related diseases caused by virus infection. The invention confirms that the molecule can promote the generation of interferon I, has the effect of inhibiting replication of viruses in organisms after the organisms are infected with the viruses and protects viscera such as livers and the like from being damaged by virus replication.

Description

technical field [0001] The invention belongs to the field of biotechnology and medicine, in particular, the invention relates to the effect, action mechanism, implementation method and application of death resistant protein (Death Resistant Protein, DRP) in viral infectious diseases. Background technique [0002] A virus is a tiny particle composed of nucleic acid (ribonucleic acid RNA or deoxyribonucleic acid DNA) as the core and protein as the shell (capsid). The nucleic acid can be divided into single strands or double strands, linear or spherical. Viruses are the smallest biological pathogens, ranging from 20nm to 300nm: the largest of which are poxviruses, such as vaccinia virus, which is 300nm × 200nm, barely visible under an ordinary light microscope; medium-sized ones such as influenza virus, with a diameter of 80 ~100nm; small viruses such as Japanese encephalitis virus, with a diameter of 20nm, can only be seen under an electron microscope [Basic Virology, Mang Keq...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/17A61K48/00A61P31/14A61P31/20A61P31/18A61P31/16A61P29/00A61P9/00A61P43/00
Inventor 陈涛涌汪晨曹雪涛
Owner SECOND MILITARY MEDICAL UNIV OF THE PEOPLES LIBERATION ARMY